|
TOMM34 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.785010E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.157700E-03 |
| Normal-vs-Stage2 |
1.949360E-01 |
| Normal-vs-Stage3 |
3.618400E-03 |
| Normal-vs-Stage4 |
1.561050E-01 |
| Stage1-vs-Stage2 |
9.037000E-01 |
| Stage1-vs-Stage3 |
6.778000E-02 |
| Stage1-vs-Stage4 |
6.483200E-01 |
| Stage2-vs-Stage3 |
2.283200E-01 |
| Stage2-vs-Stage4 |
7.375600E-01 |
| Stage3-vs-Stage4 |
5.064800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.447100E-04 |
| Normal-vs-AfricanAmerican |
6.795500E-02 |
| Normal-vs-Asian |
5.273200E-01 |
| Caucasian-vs-AfricanAmerican |
6.189800E-01 |
| Caucasian-vs-Asian |
9.528000E-01 |
| AfricanAmerican-vs-Asian |
7.997800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.232100E-02 |
| Normal-vs-Female |
8.28130000000149E-05 |
| Male-vs-Female |
3.000400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.109800E-02 |
| Normal-vs-Extreme_Weight |
2.375200E-01 |
| Normal-vs-Obese |
3.404800E-03 |
| Normal-vs-Extreme_Obese |
6.708400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.937600E-01 |
| Normal_Weight-vs-Obese |
4.821800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.358000E-01 |
| Extreme_Weight-vs-Obese |
7.815700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.815600E-01 |
| Obese-vs-Extreme_Obese |
3.875000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.958400E-02 |
| Normal-vs-Age(41-60Yrs) |
4.444200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.311980E-02 |
| Normal-vs-Age(81-100Yrs) |
5.166600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.401170E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.471550E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.569800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.183600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.419400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.387800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.309900E-02 |
| Normal-VS-Type2 PRCC |
9.351900E-02 |
| Normal-VS-KIRP CIMP |
1.376030E-02 |
| Normal-VS-Unclassified PRCC |
4.263900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.937600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.674060E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.404300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.667790E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.293700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.286200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.810600E-01 |
| Normal-vs-N1 |
2.450200E-02 |
| Normal-vs-N2 |
9.606600E-01 |
| N0-vs-N1 |
2.383200E-01 |
| N0-vs-N2 |
7.759200E-01 |
| N1-vs-N2 |
3.618600E-01 |
|
|
